Integrated Drug Expression Analysis for leukemia: an integrated in silico and in vivo approach to drug discovery.

ABSTRACT: Screening for drug compounds that exhibit therapeutic properties in the treatment of various diseases remains a challenge even after considerable advancements in biomedical research. Here, we introduce an integrated platform that exploits gene expression compendia generated from drug-treated cell lines and primary tumor tissue to identify therapeutic candidates that can be used in the treatment of acute myeloid leukemia (AML). Our framework combines these data with patient survival information to identify potential candidates that presumably have a significant impact on AML patient survival. We use a drug regulatory score (DRS) to measure the similarity between drug-induced cell line and patient tumor gene expression profiles, and show that these computed scores are highly correlated with

SUBMITTER: Ung MH 

PROVIDER: S-EPMC5243857 | biostudies-literature | 2017 Jul

REPOSITORIES: biostudies-literature